CurisFRA:CUS0 +1.64%49 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates FRA:CUS0 with a GF Score™ of 49/100 and a GF Value™ of €1.07 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 959 Biotechnology companies, Curis ranks worse than 70.39% on this metric.
OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Curis's Cash Flow from Operations for the
three
months ended in Mar. 2026 was €-7.79 Mil. Curis's Revenue for the
three
months ended in Mar. 2026 was €0.00 Mil. Therefore, Curis's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.
The historical rank and industry rank for Curis's OCF Margin % or its related term are showing as below:
FRA:CUS0'
s OCF Margin % Range Over the Past 10 Years
Min: -534.71 Med: -357.98 Max: -237.55
Current: -411.09
During the past 13 years, the highest OCF Margin % of Curis was -237.55%. The lowest was -534.71%. And the median was -357.98%.
FRA:CUS0's OCF Margin % is ranked worse than 70.39% of 959
companies
in the Biotechnology industry
Industry Median: -66.52
vs FRA:CUS0: -411.09
Curis OCF Margin % Related Terms
Curis OCF Margin % Historical Data
* Premium members only.
The historical data trend for Curis's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:CUS0 vs HOWL, TRAW, CVM: OCF Margin % Comparison
For the Biotechnology subindustry, Curis's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Curis OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Curis's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Curis's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Curis (FRA:CUS0) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Curis and its competitors. According to the industry distribution chart, Curis ranks #675 out of 959 companies in the Biotechnology industry, placing it in the top 70.4%.
Is Curis' OCF Margin % too high?
Curis' current OCF Margin % is 0.00%. Based on the distribution chart, Curis ranks #675 out of 959 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Curis has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Curis' OCF Margin % compare to HOWL and TRAW?
According to the Biotechnology industry distribution chart, Curis ranks #675 out of 959 companies for OCF Margin %. This places Curis in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Curis and its competitors. Curis's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curis stock overvalued right now?
Based on GuruFocus' analysis, Curis (FRA:CUS0) is currently considered Possible Value Trap. The stock's GF Value™ is €1.07, compared to a current price of €0.37 — trading 65.2% below its estimated fair value. The current OCF Margin % is 0.00%. Curis' overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Curis (FRA:CUS0), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Curis (FRA:CUS0) Overvalued in 2026?
Based on GuruFocus' analysis, Curis stock appears to be undervalued.
The current stock price of €0.37 is trading 65.2% below its estimated GF Value™ of €1.07.
GuruFocus considers Curis to be Possible Value Trap.
Key valuation signals for FRA:CUS0:
OCF Margin %: 0.00%
GF Value™: €1.07 vs. price of €0.37 (65.2% below fair value)
No single metric tells the full story. See the FRA:CUS0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
49GF Score
Get the complete analysis for FRA:CUS0
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:CUS0 has been successfully added to your 
